Defining Primary Refractory Diffuse Large B‐cell Lymphoma (DLBCL) Based on Survival Outcomes

$Defining Primary Refractory Diffuse Large B‐cell Lymphoma (DLBCL) Based on Survival Outcomes$

Abstract

Open access

Peer reviewed

A. M. Bock, R. Mwangi, Y. Wang, A. Khurana, M. J. Maurer, A. Ayers, B. Kahl, P. Martin, J. Cohen, C. Casulo, …

Hematological oncology, Vol.41(S2), pp.430-432

06/2023

DOI: 10.1002/hon.3164_317

Files and links (1)

url

https://doi.org/10.1002/hon.3164_317View

Published (Version of record) Open Access

Title: Subtitle: Defining Primary Refractory Diffuse Large B‐cell Lymphoma (DLBCL) Based on Survival Outcomes
Creators: A. M. Bock - Mayo Clinic
R. Mwangi - Mayo Clinic
Y. Wang - Mayo Clinic
A. Khurana - Mayo Clinic
M. J. Maurer - Mayo Clinic
A. Ayers - The University of Texas MD Anderson Cancer Center
B. Kahl - Washington University in St. Louis
P. Martin - Weill Cornell Medicine
J. Cohen - Emory University
C. Casulo - University of Rochester Medical Center
I. Lossos - University of Miami
U. Farooq - University of Iowa
S. Ayyappan - University of Iowa
T. Reicks - Mayo Clinic
T. M. Habermann - Mayo Clinic
C. R. Flowers - The University of Texas MD Anderson Cancer Center
J. R. Cerhan - Mayo Clinic
L. J. Nastoupil - The University of Texas MD Anderson Cancer Center
G. S. Nowakowski - Mayo Clinic
Resource Type: Abstract
Publication Details: Hematological oncology, Vol.41(S2), pp.430-432
DOI: 10.1002/hon.3164_317
ISSN: 0278-0232
eISSN: 1099-1069
Language: English
Date published: 06/2023
Academic Unit: Hematology, Oncology, and Blood & Marrow Transplantation; Epidemiology; Internal Medicine
Record Identifier: 9984442221202771

16 Record Views